CL
LSTA icon

CSS LLC’s Lisata Therapeutics LSTA Stock Holding History

CSS LLC’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Buy
+61,898
New +$256K 0.01% 644

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

CSS LLC's LSTA Position: Q1 2026 in Review

CSS LLC opened a new position in Lisata Therapeutics (LSTA) in Q1 2026: 61,898 shares worth $310K. The stake represents 0.01% of the portfolio and ranks #644 among its holdings.

34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • CSS LLC held 61,898 shares of Lisata Therapeutics worth $310K as of Q1 2026.
  • Lisata Therapeutics was a new CSS LLC position in Q1 2026.
  • Lisata Therapeutics made up 0.01% of CSS LLC's portfolio in Q1 2026, its #644 holding.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.